H. CRAIG DEES - Corporate Board Profile

PROVECTUS BIOPHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2004-04-29	H. Craig Dees, Ph.D., 52, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired PPI on April 23, 2002. ... The Board of Directors recommends that the stockholders vote FOR each of the nominees for election to the Board of Directors named above. ... The Board of Directors serves as our audit committee. ... The Board acting as audit committee reviews our financial reporting process. ... The Report of the Board of Directors acting as the Audit Committee: H. Craig Dees ... EXECUTIVE OFFICER COMPENSATION: The table below shows the compensation for services in all capacities we paid during the year ended December 31, 2003 to our Chief Executive Officer and the other executive officers ... H. Craig Dees........... 2003 131,250 -- 100,000 -- Chief Executive Officer ... They are compensated for their service in those roles. They are not separately compensated for their service as directors.
2008-04-29	H. Craig Dees, Ph.D., 56, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. ... As discussed below under the heading “EXECUTIVE OFFICER COMPENSATION,” they are compensated for their service in those roles. Other than the options described below, they are not separately compensated for their service as directors. ... The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2007 and 2006 to our Chief Executive Officer, and our three executive officers: ... H. Craig Dees, CEO ... Total ($) 1,315,805 ... The entire Board of Directors acts as our audit committee as permitted under Section 3(a)(58)(B) of the Securities Exchange Act of 1934 and as our nominating committee.
2009-04-30	H. Craig Dees, Ph.D., 57, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. ... The entire Board of Directors acts as our audit committee ... The entire Board of Directors acts as our nominating committee. ... Executive Officer Compensation ... Total compensation for 2008 was $1,104,110.
2009-12-01	By: /s/ H. Craig Dees H. Craig Dees, Ph.D. Chief Executive Officer
2010-04-30	H. Craig Dees, Ph.D., 58, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. Dr. Dees, who is our Chief Executive Officer, serves as chairman of our Board of Directors. Three of our five directors, Drs. Dees, Scott and Wachter, are also full-time employees. As discussed above under the heading “EXECUTIVE COMPENSATION,” they are compensated for their service in those roles. Other than the options described below, they are not separately compensated for their service as directors. The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2009 and 2008 to our Chief Executive Officer and our other two most highly compensated executive officers (which we refer to as named executive officers): Summary Compensation Table ... H. Craig Dees CEO 2009 ... Total ($) 1,107,975 ... Our entire Board of Directors acts as our audit committee, nominating committee, and compensation committee.
2011-05-02	H. Craig Dees, Ph.D., 59, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. Dr. Dees, who is our Chief Executive Officer, serves as chairman of our Board of Directors. Three of our five directors, Drs. Dees, Scott and Wachter, are also full-time employees. As discussed above under the heading "EXECUTIVE COMPENSATION," they are compensated for their service in those roles. Other than the options described below, they are not separately compensated for their service as directors. Our entire Board of Directors acts as our audit committee, nominating committee, and compensation committee.
2011-07-19	H. Craig Dees, Ph.D. - Chief Executive Officer
2013-11-15	H. Craig Dees, Ph.D. Chief Executive Officer
2015-09-01	/s/ H. Craig Dees, H. Craig Dees, Ph.D. Chief Executive Officer